ClinicalTrials.govpublic full text
A Study to Continue ASP015K Treatment to Rheumatoid Arthritis Patients Who Completed Phase IIb Study or Phase III Study of ASP015K
arthritis, rheumatoid, smyraf, rheumatoid arthritis, peficitinib, asp015k, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 813983
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.